Expert Views: Pfizer ends COVID-19 trial with 95% efficacy

[ad_1] (Reuters) – Pfizer Inc said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine showed it was 95% effective, adding it had the required two-months…

U.S. stock rout continues as virus spreads, Treasury yields sink

[ad_1] NEW YORK (Reuters) – Wall Street’s main stock indexes fell almost 2% on Tuesday as the coronavirus spread further and officials described it as “a rapidly escalating epidemic,” a…

Instant View: ECB holds rates but ramps up stimulus to counter virus impact

[ad_1] (Reuters) – The European Central Bank approved fresh stimulus measures on Thursday to help the ailing euro zone economy cope with the shock of the coronavirus pandemic but unexpectedly…

Instant view: Pfizer, BioNTech say their COVID-19 vaccine is more than 90% effective

[ad_1] (Reuters) – Pfizer Inc PFE.N said on Monday its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study, a major…